• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Catalog Number PRD-06419
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/10/2022
Event Type  malfunction  
Manufacturer Narrative
Customer was informed on how to avoid contamination of negative controls.
 
Event Description
Customer reported false positives results were observed in negative control samples when running sars cov-2 assay on the panther instrument.Hologic technical support (ts) noted that these are internally prepared samples, but there is no information given on of the formulation (e.G.Water, specimen transport media etc.), or how they are prepared.The customer reported that 7/688 of their internally prepared negative control samples have returned a false positive result.There is no specific mention in the complaint of any confirmed clinical false positive cases.The alleged 7 false-positive negative control results couldn¿t be confirmed by hologic as the data files provided by the customer didn¿t line up exactly with what was reported by the customer in the complaint record.Hologic technical support (ts) noted that because the customer only believes they reported false-positive results by running negative controls, it is not 100% certain that false-positive results were reported out.Molecular application specialist (mas) contacted the customer discussed their workflow.Hologic review of worklist (b)(4) using master lot: 317372 showed 1 suspected false positive result.There is no known product impact to date.It was noted that several different master lots have been used where false positive results are suspected, therefore product is unlikely to be the cause.There is also no indication from the customer or technical support that the cause is product related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APTIMA SARS COV-2
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer Contact
abel saluta
10210 genetic center drive
san diego, CA 92121
8584108506
MDR Report Key15204863
MDR Text Key304976495
Report Number2024800-2022-01083
Device Sequence Number1
Product Code OJR
Combination Product (y/n)N
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberPRD-06419
Device Lot Number317372
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/10/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Type of Device Usage A
Patient Sequence Number1
-
-